Integrative analysis of plasma metabolomics and proteomics reveals the metabolic landscape of breast cancer

ConclusionsThis study uncovered specific changes in the metabolic and proteomic profiling of breast cancer patients and identified a panel of 47 plasma metabolites, including sphingomyelins, glutamate, and cysteine could be potential diagnostic biomarkers for breast cancer.
Source: Cancer and Metabolism - Category: Cancer & Oncology Source Type: research